Drug Trial Radar · NCT04223349
A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants
Last checked: Nov 20, 2026Latest source record: Apr 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Jan 10, 2020
Primary completion
Apr 8, 2020
Study completion Apr 8, 2020
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Jan 10, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize the pharmacokinetic (PK) of multiple twice-daily doses of JNJ-70033093 in healthy participants and to assess the effects of dosing time and food on the PK of single-dose of JNJ-70033093 in healthy participants.
Conditions
- Healthy
Interventions
JNJ-70033093Drug
JNJ-70033093 capsules will be administered orally .
PlaceboDrug
Matching placebo in capsule will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Maximum Observed Analyte Concentration (Cmax) of JNJ-70033093Time frame: Up to Day 9
- Part 1: Time to Reach the Maximum Observed Analyte Concentration (Tmax) of JNJ-70033093Time frame: Up to Day 9
- Part 1: Area Under the Analyte Concentration-time Curve from Time Zero to 12 Hours (AUC[0-12h]) of JNJ-70033093Time frame: 12 hours postdose (Day 1)
- Part 1: Apparent Terminal Elimination Half-life (t[1/2]) of JNJ-70033093Time frame: Up to Day 9
- Part 2: Maximum Observed Analyte Concentration (Cmax) of JNJ-70033093Time frame: Up to Day 9
- Part 2: Area Under the Concentration-time Curve from Time Zero to the Last Measurable Concentration (AUC [0-last]) of JNJ-70033093Time frame: Up to Day 9
- Part 2: Area Under the Concentration-time Curve from Time Zero to Infinity (AUC [0-infinity]) of JNJ-70033093Time frame: Up to Day 9
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PRA Health Sciences
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.